Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$-0.00M |
|
$-2.28M |
|
-- |
|
$-0.00M |
|
$0.96M |
|
$-0.96M |
|
$-1.30M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-0.96M |
|
$-0.96M |
|
0.89M |
|
0.89M |
|
$-2.35 |
|
$-2.35 |
|
| Balance Sheet Financials | |
$2.03M |
|
$0.00M |
|
$5.65M |
|
$7.68M |
|
$1.45M |
|
-- |
|
$0.48M |
|
$1.93M |
|
$5.75M |
|
$5.75M |
|
$5.75M |
|
0.98M |
|
| Cash Flow Statement Financials | |
$-2.62M |
|
$-0.82M |
|
$1.43M |
|
$4.03M |
|
$1.98M |
|
$-2.06M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.62M |
|
-- |
|
-- |
|
-- |
|
-0.00 |
|
-- |
|
-0.04 |
|
-2263.69 |
|
-39.55% |
|
-39.55% |
|
-29.62% |
|
-39.55% |
|
$5.85 |
|
$-2.93 |
|
$-2.93 |
|